A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients by Woelfelschneider, A. et al.
                                         
                         
                                    





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   





   
   
     
  
          
 
  
    
 
     
   








   
 
           
  
   
  
    
     
  
  
      
  





   
   
